Cardiac Science to Present at CIBC World Markets 2004 Healthcare Conference
November 03 2004 - 1:30AM
PR Newswire (US)
Cardiac Science to Present at CIBC World Markets 2004 Healthcare
Conference IRVINE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Cardiac
Science, Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving
automated public access defibrillators, announced today that
Chairman and Chief Executive Officer Raymond W. Cohen is scheduled
to make an investor presentation at the CIBC World Markets 2004
Healthcare Conference. The presentation will be held at 8:00 a.m.
(Eastern) on Tuesday, November 9, 2004. The conference runs from
November 8-10, 2004 at the Plaza Hotel in New York, NY. A live
webcast of the Company's presentation at the Conference will be
available via a link provided at the Company's website at
http://www.cardiacscience.com/. An archive of the presentation will
begin shortly after the presentation time and will be available for
30 days. About the CIBC World Markets 2004 Healthcare Conference
This annual event features informative presentations and panels in
the pharmaceutical, biotechnology, medical device and healthcare
services industries. Attendees will have the opportunity to
increase their knowledge of today's most dynamic healthcare
companies and will gain a deeper understanding of the opportunities
and challenges facing healthcare companies today. For more
information about the conference visit:
http://www.cibcwm.com/conferences/health04/. About Cardiac Science
Cardiac Science develops, manufactures and markets a complete line
of Powerheart(R) brand, automated public access defibrillators
(AEDs), and offers comprehensive AED/CPR training and AED program
management services that facilitate successful deployments. The
company makes the Powerheart(R) CRM(TM), the only FDA-cleared
therapeutic patient monitor that instantly and automatically treats
hospitalized cardiac patients who suffer life-threatening heart
rhythms. Cardiac Science also manufactures its AED products on a
private label basis for other leading medical companies such as
Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare.
For more information please visit http://www.cardiacscience.com/ or
call 1.949.797.3800. This news release contains "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. In addition, from time to time the company, or
its representatives, have made or may make forward looking
statements orally or in writing. The words "estimate," "potential,"
"intended," "expect," "anticipate," "believe," and similar
expressions or words are intended to identify forward looking
statements. Such forward-looking statements include, but are not
limited to the achievement of future revenue growth and the
lowering of the company's breakeven revenue level by the third
quarter. Cardiac Science cautions that these statements are subject
to substantial risks and uncertainties and are qualified by
important factors that could cause actual results to differ
materially from those reflected by the forward-looking statements
and should not be relied upon by investors when making an
investment decision. Information on these and other factors is
detailed in the Company's Form 10-K for the year ending December
31, 2003, subsequent quarterly filings, and other documents filed
by the Company with the Securities and Exchange Commission. For
further information please contact: Matt Clawson (Investors), Allen
& Caron Inc, +1-949-474-4300, , for Cardiac Science, Inc.; or
Roderick de Greef, EVP and CFO of Cardiac Science, Inc.,
+1-949-797-3800, DATASOURCE: Cardiac Science, Inc. CONTACT: Matt
Clawson (Investors), Allen & Caron Inc, +1-949-474-4300, , for
Cardiac Science, Inc.; or Roderick de Greef, EVP and CFO of Cardiac
Science, Inc., +1-949-797-3800, Web site:
http://www.cardiacscience.com/
Copyright
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jul 2023 to Jul 2024